Last $9.82 USD
Change Today +0.06 / 0.61%
Volume 38.1K
CLDN On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

celladon corp (CLDN) Snapshot

Open
$9.81
Previous Close
$9.76
Day High
$9.90
Day Low
$9.65
52 Week High
03/17/14 - $17.16
52 Week Low
02/4/14 - $7.45
Market Cap
221.3M
Average Volume 10 Days
51.1K
EPS TTM
$-15.10
Shares Outstanding
22.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CELLADON CORP (CLDN)

Related News

No related news articles were found.

celladon corp (CLDN) Related Businessweek News

No Related Businessweek News Found

celladon corp (CLDN) Details

Celladon Corporation, a clinical-stage biotechnology company, focuses on developing treatments for heart failure, diabetes, and neurodegenerative diseases. The company’s lead product candidate includes MYDICAR that uses genetic enzyme replacement therapy to correct the Sarco/endoplasmic reticulum Ca 2+ -ATPase 2a enzyme deficiency in heart failure patients that results in inadequate pumping of the heart. Its MYDICAR product is developed to treat patients with systolic heart failure, diastolic heart failure, and advanced heart failure, as well as to treat pulmonary arterial hypertension and arteriovenous fistula maturation failure. The company was founded in 2000 and is headquartered in San Diego, California.

22 Employees
Last Reported Date: 08/7/14
Founded in 2000

celladon corp (CLDN) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $417.5K
Principal Financial & Accounting Officer and ...
Total Annual Compensation: $216.3K
Vice President of Corporate Development & Inv...
Total Annual Compensation: $190.4K
Vice President of Clinical Operations
Total Annual Compensation: $216.3K
Compensation as of Fiscal Year 2013.

celladon corp (CLDN) Key Developments

Celladon Corporation Presents at Stem Cell Meeting on the Mesa Partnering Forum, Oct-08-2014 04:15 PM

Celladon Corporation Presents at Stem Cell Meeting on the Mesa Partnering Forum, Oct-08-2014 04:15 PM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States.

Celladon Corporation Appoints Scott Garrett as Vice President, Commercial Planning

Celladon Corporation announced it has appointed Scott Garrett as Vice President, Commercial Planning, a newly created position. Mr. Garrett brings 20 years of biopharmaceutical industry experience, a majority which has been focused on the commercialization of novel cardiovascular products. Prior to Celladon, Mr. Garrett served as Vice President, Marketing, Hospital Division for Mallinckrodt Pharmaceuticals (previously Cadence Pharmaceuticals) from 2011 to 2014.

Celladon Corporation Presents at The 21st Annual NewsMakers in the Biotech Industry 2014, Sep-26-2014 09:00 AM

Celladon Corporation Presents at The 21st Annual NewsMakers in the Biotech Industry 2014, Sep-26-2014 09:00 AM. Venue: Millennium Broadway Hotel & Conference Center, 145 West 44th Street, New York, New York, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLDN:US $9.82 USD +0.06

CLDN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLDN.
View Industry Companies
 

Industry Analysis

CLDN

Industry Average

Valuation CLDN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLADON CORP, please visit www.celladon.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.